Acuitas Therapeutics Video Update
Acuitas Therapeutics is the global leader in the field of lipid nanotechnology. We specialize in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticles (LNP). We work with partners to develop new therapies to address unmet
An Interview with Dr. Thomas Madden, Ph.D.
Acuitas Therapeutics President & CEO, Dr. Thomas Madden, was recently interviewed about the work we do, our proprietary lipid nanoparticle delivery system, and how we support partners worldwide in the development of COVID-19 vaccines. It’s a great overview of who
mRNA-LNP COVID-19 Vaccines
When asked about the work we do at Acuitas Therapeutics by those who aren’t in our field, it can be a little challenging to explain. We specialize in the development of lipid nanoparticle delivery systems for molecular therapeutics, which sounds
A Little About Us…
As we work to increase engagement with our stakeholders and members of the public who are interested in the work that we do, we thought it would be a good idea to share a little about us. Acuitas Therapeutics is